Loading...
Loading...
India's metoprolol imports from UNITED STATES total $1.3B across 244 shipments from 15 foreign suppliers. GRANULES PHARMACEUTICALS, INC leads with $1.3B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GRANULES INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for metoprolol โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

GRANULES PHARMACEUTICALS, INC is the leading Metoprolol supplier from UNITED STATES to India, with import value of $1.3B across 6 shipments. The top 5 suppliers โ GRANULES PHARMACEUTICALS, INC, GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICAL INC, M/S RISING PHARMA HOLDINGS, ACTAVIS ELIZABETH LLC โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRANULES PHARMACEUTICALS, INC | $1.3B | 6 | 99.8% |
| 2 | GRANULES PHARMACEUTICALS INC | $2.9M | 63 | 0.2% |
| 3 | GRANULES PHARMACEUTICAL INC | $88.3K | 2 | 0.0% |
| 4 | M/S RISING PHARMA HOLDINGS | $20.0K | 1 | 0.0% |
| 5 | ACTAVIS ELIZABETH LLC | $19.9K | 74 | 0.0% |
| 6 | AMSTERDAM PHARMA APTEKA RX INC | $11.5K | 9 | 0.0% |
| 7 | Granules Pharmaceuticals Inc | $7.4K | 4 | 0.0% |
| 8 | Raff & Hall Pharmacy | $5.0K | 2 | 0.0% |
| 9 | AGRACE PHARMA | $4.7K | 6 | 0.0% |
| 10 | NEWLIFE MEDICALS (USA). INC | $2.9K | 1 | 0.0% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC | $2.8K | 6 | 0.0% |
| 12 | AMSTERDAM PHARMA | $2.4K | 4 | 0.0% |
| 13 | NEW LIFE MEDICALS USA Inc | $1.9K | 8 | 0.0% |
| 14 | SPRING BIO SOLUTION | $1.9K | 4 | 0.0% |
| 15 | M/S. SUN PHARMACEUTICAL INDUSTRIES | $1.7K | 4 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED | $1.3B | 75 | 100.0% |
| 2 | AUROBINDO PHARMA LTD | $20.2K | 16 | 0.0% |
| 3 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $17.2K | 62 | 0.0% |
| 4 | MSN LABORATORIES PRIVATE LIMITED | $16.5K | 11 | 0.0% |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $4.7K | 6 | 0.0% |
| 6 | AJANTA PHARMA LIMITED | $4.1K | 7 | 0.0% |
| 7 | MICRO LABS LIMITED | $3.9K | 9 | 0.0% |
| 8 | IPCA LABORATORIES LIMITED | $2.9K | 1 | 0.0% |
| 9 | ACTAVIS PHARMA DEVELOPMENT CENTRE PVT.LTD. | $2.5K | 6 | 0.0% |
| 10 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.2K | 4 | 0.0% |
| 11 | INDOCO REMEDIES LIMITED | $1.9K | 8 | 0.0% |
| 12 | DR.REDDY'S LABORATORIES LTD | $1.4K | 4 | 0.0% |
| 13 | XYLOPIA LABS PRIVATE LIMITED | $1.2K | 5 | 0.0% |
| 14 | HETERO LABS LIMITED | $964 | 1 | 0.0% |
| 15 | MYLAN LABORATORIES LIMITED | $878 | 9 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Metoprolol suppliers from UNITED STATES to India include GRANULES PHARMACEUTICALS, INC, GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICAL INC. The leading supplier is GRANULES PHARMACEUTICALS, INC with import value of $1.3B USD across 6 shipments. India imported Metoprolol worth $1.3B USD from UNITED STATES in total across 244 shipments.
India imported Metoprolol worth $1.3B USD from UNITED STATES across 244 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Metoprolol sourced from UNITED STATES include GRANULES INDIA LIMITED, AUROBINDO PHARMA LTD, ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is GRANULES INDIA LIMITED with $1.3B in imports across 75 shipments.
The total value of Metoprolol imports from UNITED STATES to India is $1.3B USD, across 244 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
244 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists